摘要
目的采用分子对接技术预测苓桂术甘汤防治慢性心力衰竭的作用机制。方法运用分子对接软件MOE(Molecule Operating Environment),将苓桂术甘汤中的特征性化学成分与AMPK/SIRT1/NF-κB炎症信号通路中的关键靶点AMPK、SIRT1、IKKβ进行分子对接,对分子对接结果进行分析。结果甘草苷与AMPK、SIRT1、IKKβ靶点的结合能力均高于自身配体,其他化学成分与AMPK、SIRT1、IKKβ靶点均有不同程度的结合。结论分子对接技术预测苓桂术甘汤可能作用于AMPK/SIRT1/NF-κB炎症信号通路,为揭示苓桂术甘汤防治慢性心力衰竭的抗炎作用机制提供理论依据。
Objective On the basis of molecular docking,to predict the mechanism of Linggui Zhugan Decoction in preventing and treating chronic heart failure.Methods Characteristic constituents of Linggui Zhugan Decoction docked with AMPK,SIRT1 and IKKβtargets of AMPK/SIRT1/NF-κB signaling pathway by using Molecule Operating Environment(MOE)software.Results The binding capacity of liquiritin to AMPK,SIRT1 and IKKβtargets are higher than those of their own ligands.Other chemical components have different degrees of binding with AMPK,SIRT1 and IKKβtargets.Conclusion Molecular docking predicts that Linggui Zhugan Decoction may play an important role in AMPK/SIRT1/NF-κB signaling pathway,and it will provide a theoretical basis for revealing the anti-inflammatory mechanism of Linggui Zhugan Decoction in preventing and treating chronic heart failure.
作者
周鹏
杨建澳
许继公
王国强
李莹莹
丁婉雪
王靓
黄金玲
ZHOU Peng;YANG Jianao;XU Jigong;WANG Guoqiang;LI Yingying;DING Wanxue;WANG Liang;HUANG Jinling(Department of Integrated Traditional Chinese and Western Medicine,Anhui University of Chinese Medicine,Hefei 230012,China;Research Institute of Integrated Traditional Chinese and Western Medicine,Anhui Academy of Chinese Medicine,Hefei 230012,China;Anhui Province Key Laboratory of Chinese Medicinal Formula,Hefei 230012,China)
出处
《云南中医学院学报》
2018年第4期82-87,共6页
Journal of Yunnan University of Traditional Chinese Medicine
基金
国家自然科学基金面上项目(81373533)
安徽高校自然科学研究重点项目(KJ2017A303)
2017年研究生科技创新基金(2017YB12)
安徽中医药大学2018年度大学生创新创业基金项目(2018158)